Probucol - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for probucol and what is the scope of freedom to operate?
Probucol
is the generic ingredient in one branded drug marketed by Sanofi Aventis Us and is included in one NDA. Additional information is available in the individual branded drug profile pages.There are six drug master file entries for probucol.
Summary for probucol
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Drug Master File Entries: | 6 |
Raw Ingredient (Bulk) Api Vendors: | 108 |
Clinical Trials: | 20 |
Patent Applications: | 6,668 |
DailyMed Link: | probucol at DailyMed |
Recent Clinical Trials for probucol
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
General Hospital of Shenyang Military Region | Phase 4 |
Weston Brain Institute | Phase 1/Phase 2 |
McGill University | Phase 1/Phase 2 |
Medical Subject Heading (MeSH) Categories for probucol
Anatomical Therapeutic Chemical (ATC) Classes for probucol
US Patents and Regulatory Information for probucol
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sanofi Aventis Us | LORELCO | probucol | TABLET;ORAL | 017535-002 | Jul 6, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Sanofi Aventis Us | LORELCO | probucol | TABLET;ORAL | 017535-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for probucol
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sanofi Aventis Us | LORELCO | probucol | TABLET;ORAL | 017535-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Sanofi Aventis Us | LORELCO | probucol | TABLET;ORAL | 017535-002 | Jul 6, 1988 | ⤷ Sign Up | ⤷ Sign Up |
Sanofi Aventis Us | LORELCO | probucol | TABLET;ORAL | 017535-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |